(Reuters) -Shares in European vaccine makers fell on Friday after U.S. President-elect Donald Trump picked Robert F. Kennedy ...

Pfizer's stock dropped 4.3 percent while Moderna's fell 3.1 percent and Novavax saw a 2.8 percent dip in its stock Friday ...

Pharmaceutical company shareholders were “spooked” this week after President-elect Donald Trump announced that he would ...

Applied Materials tumbles after issuing a disappointing fiscal first-quarter outlook, Palantir is transferring its stock listing to the Nasdaq, and Tesla rises following a decline on worries President ...

The standout company among those yet to report is Nvidia Corp. (NVDA), which is scheduled to announce quarterly results on Wednesday.

If you missed the early fall push for flu and COVID-19 vaccines, it’s not too late. Health officials say it’s important to ...

U.S. stocks fell to their worst loss since Election Day as the boost that Wall Street got from last week’s victory for Donald ...

Pfizer stock and other vaccine shares tumbled Friday morning after Trump picked Kennedy to lead the Department of Health and ...

Donald Trump has delivered a blow to the drug makers he claims hampered his 2020 election bid with the appointment of vaccine ...

Having been floated as a possible chair by exactly one person, former Chicago Mayor Rahm Emanuel has indicated he wants the ...

Vaccine stocks have struggled since RFK Jr.'s appointment to health secretary, with Moderna and Pfizer seeing the deepest ...

Remember when everyone was excited the stock market spiked after Trump’s election win? Well, turns out it was very short-lived.